IHS Chemical Week

Regions :: North America :: U.S.

AMRI to shut Syracuse site

8:11 AM MDT | April 21, 2014 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says that it will transition discovery and development services (DDS) activities at its Syracuse, NY, site to other sites within AMRI and will cease operations at Syracuse by the end of June. This research center provides services, including chemical process R&D, custom chemical synthesis, and scale-up of pharmaceutical intermediates and final products, to the global pharmaceutical industry. As part of the transition, Syracuse DDS capabilities and some employees will transfer to a number of AMRI...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa